Application

CTX310

CRISPR Therapeutics AG

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97461217
Filing Date: 06/16/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97461217
MARK INFORMATION
*MARK CTX310
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT CTX310
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK CRISPR Therapeutics AG
*MAILING ADDRESS Baarerstrasse 14
*CITY ZUG V8 SWITZERLAND
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Switzerland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
6300
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE aktiengesellschaft
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Switzerland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Tiffany D. Gehrke
ATTORNEY DOCKET NUMBER 33324/60061
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Marshall, Gerstein & Borun LLP
INTERNAL ADDRESS 6300 Willis Tower
STREET 233 South Wacker Drive
CITY Chicago
STATE Illinois
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 60606
PHONE 312-474-6300
EMAIL ADDRESS docket@marshallip.com
CORRESPONDENCE INFORMATION
NAME Tiffany D. Gehrke
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docket@marshallip.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) kkleinwachter@marshallip.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 700
*TOTAL FEES PAID 700
SIGNATURE INFORMATION
SIGNATURE NOT PROVIDED
SIGNATORY'S NAME NOT PROVIDED
SIGNATORY'S POSITION NOT PROVIDED
DATE SIGNED NOT PROVIDED



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97461217
Filing Date: 06/16/2022

To the Commissioner for Trademarks:

MARK: CTX310 (Standard Characters, see mark)
The literal element of the mark consists of CTX310. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, CRISPR Therapeutics AG, a aktiengesellschaft legally organized under the laws of Switzerland, having an address of
      Baarerstrasse 14
      ZUG V8 SWITZERLAND 6300
      Switzerland
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Tiffany D. Gehrke. Tiffany D. Gehrke of Marshall, Gerstein & Borun LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      6300 Willis Tower
      233 South Wacker Drive
      Chicago, Illinois 60606
      United States
      312-474-6300(phone)
      docket@marshallip.com
The docket/reference number is 33324/60061.
Tiffany D. Gehrke submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Tiffany D. Gehrke
       PRIMARY EMAIL FOR CORRESPONDENCE: docket@marshallip.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kkleinwachter@marshallip.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Signatory's Phone Number: Not Provided
Payment Sale Number: 97461217
Payment Accounting Date: 06/16/2022

Serial Number: 97461217
Internet Transmission Date: Thu Jun 16 10:19:29 ET 2022
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2022061610192983
9908-97461217-82007752c7293b6891c7e405a6
22192d73976164f6eb43cdd5a7db6f825394df7-
CC-19284006-20220616100810206826

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed